Stenkem Biolife Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 2 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.74 Cr
About Stenkem Biolife
Stenkem Biolife Private Limited (SBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 16 December 2022 (Two years and two months 8 days old ). Its registered office is in Karnal, Haryana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹1.74 Cr.
Rajesh Kumar, Sangeeta Rani, and Khushal Arora serve as directors at the Company.
Company Details
- Location
Karnal, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290HR2022PTC108453
- Company No.
108453
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Stenkem Biolife?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Kumar  | Director | 16-Dec-2022 | Current |
| Sangeeta Rani | Director | 16-Dec-2022 | Current |
| Khushal Arora | Director | 16-Dec-2022 | Current |
Financial Performance of Stenkem Biolife.
Enhance accessibility to Stenkem Biolife's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Stenkem Biolife?
Unlock access to Stenkem Biolife's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Stenkem Molecules Private LimitedRajesh Kumar and Sangeeta Rani are mutual person
Semmax Printing Private LimitedRajesh Kumar and Sangeeta Rani are mutual person
Charges (Loans)
₹17.45 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.74 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 May 2024 | Others | ₹1.98 M | Open |
| 10 May 2023 | Others | ₹1.55 Cr | Open |
How Many Employees Work at Stenkem Biolife?
Stenkem Biolife has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stenkem Biolife, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stenkem Biolife's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.